Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
Abstract
Advances in antiplatelet therapies for patients with cardiovascular disease have improved patient outcomes over time, but the challenge of balancing the risks of ischaemia and bleeding remains substantial. Moreover, many patients with cardiovascular disease have a residual risk of ischaemic events despite receiving antiplatelet therapy. Therefore, novel strategies are needed to prevent clinical events through mechanisms beyond platelet...
Paper Details
Title
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease
Published Date
Jan 17, 2020
Journal
Volume
17
Issue
4
Pages
242 - 257
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History